Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not

被引：1
|
作者：
Paulino, Eduardo [1 ]
机构：
[1] Brazilian Natl Canc Inst, BR-20081250 Rio De Janeiro, Brazil
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷 / 04期
关键词：
D O I：
10.1136/ijgc-2022-003419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [1] Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
    Van Le, Linda
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (05) : 275 - 276
  • [2] Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
    Makker, V
    Colombo, N.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Baron-Hay, S.
    Ray-Coquard, I
    Shapira-Frommer, R.
    Ushijima, K.
    Sakata, J.
    Yonemori, K.
    Kim, Y. M.
    Guerra, E. M.
    Sanli, U. A.
    McCormack, M. M.
    Smith, A. D.
    Keefe, S.
    Bird, S.
    Dutta, L.
    Orlowski, R. J.
    Lorusso, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 437 - 448
  • [3] Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
    Makker, Vicky
    Taylor, Matthew H.
    Aghajanian, Carol
    Oaknin, Ana
    Mier, James
    Cohn, Allen L.
    Romeo, Margarita
    Bratos, Raquel
    Brose, Marcia S.
    DiSimone, Christopher
    Messing, Mark
    Stepan, Daniel E.
    Dutcus, Corina E.
    Wu, Jane
    Schmidt, Emmett V.
    Orlowski, Robert
    Sachdev, Pallavi
    Shumaker, Robert
    Casado Herraez, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2981 - 2992
  • [4] Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) : 464 - 464
  • [5] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results
    Makker, Vicky
    Rasco, Drew
    Vogelzang, Nicholas J.
    Messing, Mark
    Brose, Marcia S.
    Cohn, Allen L.
    Aghajanian, Carol
    Stepan, Daniel E.
    Dutcus, Corina
    Schmidt, Emmett
    Guo, Matthew
    Sachdev, Pallavi
    Shumaker, Robert
    Young, Louise
    Taylor, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 175 - 175
  • [6] Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 610 - 610
  • [7] A potential inflammatory biomarker for advanced endometrial cancer treated with lenvatinib plus pembrolizumab
    Yanazume, Shintaro
    Kobayashi, Yusuke
    Kirita, Yukari
    Kitazono, Ikumi
    Nagata, Chikako
    Kozai, Ayumi
    Tanimoto, Akihide
    Kobayashi, Hiroaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2025, 51 (01)
  • [8] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results.
    Makker, Vicky
    Rasco, Drew W.
    Vogelzang, Nicholas J.
    Messing, Mark
    Brose, Marcia S.
    Cohn, Allen Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
    Walker, Christopher A.
    Spirtos, Alexandra N.
    Miller, David S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 361 - 368
  • [10] Lenvatinib plus pembrolizumab in advanced recurrent endometrial cancer: a cost-effectiveness analysis
    Barrington, David
    Calhoun, Cody
    Haight, Paulina
    Tubbs, Crystal
    Cohn, David
    Bixel, Kristin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S35 - S35
12345